Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series

Siponimod, a selective modulator of sphingosine 1-phosphate receptors 1 (S1P1) and 5 (S1P5), has recently been marketed for patients with Secondary Progressive Multiple Sclerosis (SPMS). Herein, we report three SPMS patients presenting disease reactivation in the first three months after switching f...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbadessa, Gianmarco, Maida, Elisabetta, Miele, Giuseppina, Bile, Floriana, Lavorgna, Luigi, Bonavita, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605018/
https://www.ncbi.nlm.nih.gov/pubmed/36294354
http://dx.doi.org/10.3390/jcm11206033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605018/
https://www.ncbi.nlm.nih.gov/pubmed/36294354
http://dx.doi.org/10.3390/jcm11206033

Ejemplares similares